Skip to Main Content
Contribute Try STAT+ Today

The CEO of the SENS Research Foundation left his job and seat on the organization’s board in July amid an investigation into sexual harassment allegations against the anti-aging nonprofit’s high-profile co-founder, Aubrey de Grey, STAT has learned. The departure of chief executive Jim O’Neill is, in part, what prompted two female entrepreneurs to go public this week with their charges, out of fear the foundation’s investigation would be compromised, they told STAT in interviews.

On Tuesday, Laura Deming, the founder of Longevity Fund, and Celine Halioua, CEO of Loyal, published a pair of blog posts accusing de Grey of making inappropriate remarks to them early in their careers, when he was serving as their mentor. Deming was just 17 years old at the time. The women also alleged that SENS had known about their experiences since June and looked the other way while de Grey helped the organization raise more than $20 million through a donation drive last month, during a time when, SENS has said, he’d been placed on leave as chief science officer pending the outcome of the investigation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment